These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
358 related items for PubMed ID: 20884965
1. Quantitative proteomics and transcriptomics addressing the estrogen receptor subtype-mediated effects in T47D breast cancer cells exposed to the phytoestrogen genistein. Sotoca AM, Gelpke MD, Boeren S, Ström A, Gustafsson JÅ, Murk AJ, Rietjens IM, Vervoort J. Mol Cell Proteomics; 2011 Jan; 10(1):M110.002170. PubMed ID: 20884965 [Abstract] [Full Text] [Related]
9. Influence of cellular ERalpha/ERbeta ratio on the ERalpha-agonist induced proliferation of human T47D breast cancer cells. Sotoca AM, van den Berg H, Vervoort J, van der Saag P, Ström A, Gustafsson JA, Rietjens I, Murk AJ. Toxicol Sci; 2008 Oct; 105(2):303-11. PubMed ID: 18644836 [Abstract] [Full Text] [Related]
15. Cell proliferation and modulation of interaction of estrogen receptors with coregulators induced by ERα and ERβ agonists. Evers NM, van den Berg JH, Wang S, Melchers D, Houtman R, de Haan LH, Ederveen AG, Groten JP, Rietjens IM. J Steroid Biochem Mol Biol; 2014 Sep; 143():376-85. PubMed ID: 24923734 [Abstract] [Full Text] [Related]
20. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft. Saxena R, Fatima I, Chandra V, Blesson CS, Kharkwal G, Hussain MK, Hajela K, Roy BG, Dwivedi A. Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847 [Abstract] [Full Text] [Related] Page: [Next] [New Search]